DEVELOPMENT OF A CANDIDATE SYNTHETIC VACCINE FOR IMMUNOTHERAPY OF MELANOMA
- 作者: Borobova E.1, Antonets D.1, Starostina E.1
-
隶属关系:
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology «Vector»
- 期: 卷 22, 编号 2-2 (2019)
- 页面: 1003-1005
- 栏目: ORIGINAL ARTICLES
- URL: https://journals.rcsi.science/1028-7221/article/view/120236
- DOI: https://doi.org/10.31857/S102872210006491-5
- ID: 120236
如何引用文章
全文:
详细
Melanoma is the most dangerous skin cancer. It’s characterized by rapid growth rates and high incidences of metastasis. Melanoma cells have tumor antigens on their surfaces. Thereby, it’s possible to create an eff ective vaccine against melanoma. Earlier in the Federal Budgetary Research Institution State Research Center of Virology and Biotechnology «Vector» DNA-constructs, encoding artifi cial polyepitope immunogens MEL-A0201 and MEL-TCI, that consist of cytotoxic and helper T-cell epitope form six melanoma antigens, were created. This article includes the results of evaluation of the capability of designed DNA-constructs to induce antitumor immune response.
作者简介
E. Borobova
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology «Vector»
编辑信件的主要联系方式.
Email: borobova-elena@rambler.ru
researcher,
Koltsovo, Novosibirsk region
俄罗斯联邦D. Antonets
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology «Vector»
Email: fake@neicon.ru
PhD, senior researcher,
Koltsovo, Novosibirsk region
俄罗斯联邦E. Starostina
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology «Vector»
Email: fake@neicon.ru
researcher,
Koltsovo, Novosibirsk region
俄罗斯联邦参考
- Siegel R, Miller K, Jemal A. Cancer Statistics, 2018. Ca-a Cancer Journal for Clinicians. 2018, 68(1), 7–30. doi: 10.3322/caac.21442.
- Pitcovski J., Shahar E., Aizenshtein E, Gorodetsky R. Melanoma antigens and related immunological markers. Critical Reviews in Oncology/Hematology. 2017, Vol. 115, P. 36–49.
- Liu M. DNA vaccines: an historical perspective and view to the future. Immunological reviews. 2011. Vol. 239. P. 62–84
- Боробова Е. А., Антонец Д. В., Старостина Е. В., Смирнова О. Ю., Щербаков Д. Н., Волкова О. Ю., Орешкова С. Ф., Карпенко Л. И., Ильичев А. А., Бажан С. И. Кандидаты ДНК-вакцины против меланомы: дизайн, конструирование и оценка экспрессии целевых генов в эукариотических клетках. Новосибирский государственный университет. 2012, 10(5), 23–30.
- Park M., Yang D., Kim M., Jang J., Jang Y., Lee Y., Jin C., Pham T., Thi T., Lim M., Lee H., Hong C., Yoon J., Lee J. Alpha-type 1 polarized dendritic cells loaded with apoptotic allogeneic breast cancer cells can induce potent cytotoxic t lymphocytes against breast cancer. Cancer Res Treat. 2011, 43(1), 56–66.
